Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 2 2 Phase 3 1 Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 117 Neoplasms 101 Prostatic Neoplasms 76 Carcinoma, Non-Small-Cell Lung 75 Colorectal Neoplasms 73 Carcinoma, Hepatocellular 67 Leukemia, Myeloid, Acute 59 Stomach Neoplasms 52 Neoplasm Metastasis 50 Lung Neoplasms 48 Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Pancreatic Neoplasms 40 Recurrence 36 Head and Neck Neoplasms 32 Rectal Neoplasms 30 Colonic Neoplasms 30 Leukemia 29 Multiple Myeloma 28 Ovarian Neoplasms 26 Lymphoma 25 Squamous Cell Carcinoma of Head and Neck 24 Hematologic Neoplasms 23 Melanoma 22 Urinary Bladder Neoplasms 20 Liver Neoplasms 20 Polycystic Ovary Syndrome 19 Myelodysplastic Syndromes 19 Lymphoma, Large B-Cell, Diffuse 19 Esophageal Neoplasms 19 Uterine Cervical Neoplasms 16

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Interventional × Ameloblastoma × Clear all

NCT06819605 2025-02-11

NETCAM-RCT

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 2/3 Not yet recruiting

Ameloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡